Organigram (OGI) Competitors C$1.48 +0.03 (+2.07%) As of 04/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock OGI vs. CMED, EMC, WEED, ICC, LEAF, MGW, BE, BLO, SL, and MJNShould you be buying Organigram stock or one of its competitors? The main competitors of Organigram include CanniMed Therapeutics (CMED), Emblem (EMC), Canopy Growth (WEED), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry. Organigram vs. CanniMed Therapeutics Emblem Canopy Growth ICC Labs Leaf Mobile Maple Leaf Green World Beleave Cannabix Technologies Supreme Cannabis Company Inc, Cronos Group CanniMed Therapeutics (TSE:CMED) and Organigram (TSE:OGI) are both small-cap manufacturing companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership. Do analysts recommend CMED or OGI? Organigram has a consensus target price of C$3.67, suggesting a potential upside of 147.75%. Given Organigram's stronger consensus rating and higher possible upside, analysts plainly believe Organigram is more favorable than CanniMed Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CanniMed Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Organigram 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CMED or OGI more profitable? CanniMed Therapeutics has a net margin of 0.00% compared to Organigram's net margin of -31.69%. CanniMed Therapeutics' return on equity of 0.00% beat Organigram's return on equity.Company Net Margins Return on Equity Return on Assets CanniMed TherapeuticsN/A N/A N/A Organigram -31.69%-17.59%-5.56% Does the MarketBeat Community believe in CMED or OGI? CanniMed Therapeutics received 108 more outperform votes than Organigram when rated by MarketBeat users. Likewise, 75.85% of users gave CanniMed Therapeutics an outperform vote while only 44.95% of users gave Organigram an outperform vote. CompanyUnderperformOutperformCanniMed TherapeuticsOutperform Votes15775.85% Underperform Votes5024.15% OrganigramOutperform Votes4944.95% Underperform Votes6055.05% Which has better valuation and earnings, CMED or OGI? CanniMed Therapeutics has higher earnings, but lower revenue than Organigram. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCanniMed TherapeuticsN/AN/AN/AN/AN/AOrganigramC$180.58M1.01-C$57.23M-C$0.47-3.13 Do insiders and institutionals hold more shares of CMED or OGI? 8.4% of Organigram shares are held by institutional investors. 31.3% of Organigram shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to CMED or OGI? In the previous week, Organigram's average media sentiment score of 0.45 beat CanniMed Therapeutics' score of 0.00 indicating that Organigram is being referred to more favorably in the news media. Company Overall Sentiment CanniMed Therapeutics Neutral Organigram Neutral SummaryOrganigram beats CanniMed Therapeutics on 7 of the 12 factors compared between the two stocks. Get Organigram News Delivered to You Automatically Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGI vs. The Competition Export to ExcelMetricOrganigramDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$182.84MC$2.13BC$5.31BC$5.53BDividend YieldN/A2.92%5.45%6.44%P/E Ratio-3.134.3321.8829.92Price / Sales1.01478.32380.66583.88Price / Cash3.8510.2538.2683.35Price / Book0.526.146.453.53Net Income-C$57.23MC$20.70BC$3.22BC$300.83M1 Month Performance-3.90%-3.01%-9.75%-3.71%1 Year Performance-43.30%93.89%11.50%11.14% Organigram Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGIOrganigram2.7611 of 5 starsC$1.48+2.1%C$3.67+147.7%-42.9%C$182.84MC$180.58M-3.13987CMEDCanniMed TherapeuticsN/AN/AN/AN/AC$668.44MN/A0.00147,000EMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AWEEDCanopy Growth1.4521 of 5 starsC$1.43+10.0%C$5.64+294.3%-84.9%C$230.04MC$519.68M-0.212,700ICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533,684.0095.29N/AGap UpLEAFLeaf MobileN/AN/AN/AN/AC$198.42MC$83.74M58.86150MGWMaple Leaf Green WorldN/AC$0.79+777.8%N/A+0.0%C$111.69MN/A0.00N/APositive NewsGap UpBEBeleaveN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeBLOCannabix TechnologiesN/AN/AN/AN/AC$0.00N/A0.00N/AGap DownSLSupreme Cannabis Company Inc,N/AN/AN/AN/AC$0.00N/A0.00N/AGap DownHigh Trading VolumeMJNCronos GroupN/AC$12.15-1.9%N/A+0.0%C$1.73BN/A0.007,600 Related Companies and Tools Related Companies CanniMed Therapeutics Competitors Emblem Competitors Canopy Growth Competitors ICC Labs Competitors Leaf Mobile Competitors Maple Leaf Green World Competitors Beleave Competitors Cannabix Technologies Competitors Supreme Cannabis Company Inc, Competitors Cronos Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:OGI) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OGI Stock Free OGI Stock Alerts